Medicare and Medicaid have approved a new test for two blood cancers that was developed by Washington University in St. Louis. Dr. Richard Cote (CODY) at the School of Medicine says the test advances precision, or personalized, medicine for blood cancer treatment by identifying genetic changes in cancer cells…

Demand for this test is expected to skyrocket across the U.S. now that it’s going to be covered by Medicare. Cote (CODY) hopes to expand the test to treat other kinds of cancers in the future.

(From Missourinet)